Skip to content

Vecuronium

Nondepolarizing Neuromuscular Blocker — MUSCULO-SKELETAL SYSTEM

Also known as: Org NC 45, vecuronium bromide, vecuronium citrate, vecuronium HCl, vecuronium hydrobromide, vecuronium hydrochloride, vecuronium maleate

OfpFDA approvedATC M03AC03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Vecuronium is an ofp drug in the Nondepolarizing Neuromuscular Blocker class catalogued in DrugCentral. It was first approved by the FDA in 1984. DrugCentral lists 13 molecular targets, including CHRM1, CHRM4 and CHRM5. Recorded indications include General anesthesia, Muscle relaxation, function and Skeletal Muscle Relaxation for Endotracheal Intubation.

  • Approval status: ofp (first approved 1984 by the FDA).
  • Drug class: Nondepolarizing Neuromuscular Blocker.
  • Molecular targets: CHRM1, CHRM4, CHRM5 and CHRM3 (13 listed in DrugCentral).
  • Indications: General anesthesia, Muscle relaxation, function and Skeletal Muscle Relaxation for Endotracheal Intubation.
  • ATC code: M03AC03 (Other quaternary ammonium compounds).
  • Molecular formula: C34H57N2O4; molecular weight 557.84 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • General anesthesia
  • Muscle relaxation, function
  • Skeletal Muscle Relaxation for Endotracheal Intubation

Contraindications (7)

  • Cirrhosis of liver
  • Disorder of electrolytes
  • Eaton-Lambert syndrome
  • Morbid obesity
  • Myasthenia gravis
  • Neuromyopathy
  • Obstruction of bile duct

Mechanism & targets

Established pharmacologic classNondepolarizing Neuromuscular Blocker

Molecular targets (13)

TargetGeneActionActivity
Muscarinic acetylcholine receptor M1CHRM1unknownIC50 9.90
Muscarinic acetylcholine receptor M4CHRM4unknownIC50 9.80
Muscarinic acetylcholine receptor M5CHRM5unknownIC50 9.70
Muscarinic acetylcholine receptor M3CHRM3unknownIC50 9.60
Muscarinic acetylcholine receptor M2CHRM2unknownIC50 9.30
Acetylcholine receptorCHRNA1|CHRNB1|CHRNDantagonistIC50 7.82
Acetylcholine receptor; alpha1/beta1/delta/gammaCHRNA1|CHRNG|CHRNB1|CHRNDunknownIC50 7.09
Multidrug and toxin extrusion protein 1SLC47A1unknownIC50 5.72
Solute carrier family 22 member 2SLC22A2unknownIC50 5.46
Multidrug and toxin extrusion protein 2SLC47A2unknownIC50 4.60
Neuronal acetylcholine receptor; alpha4/beta2CHRNB2|CHRNA4unknown—
Neuronal acetylcholine receptor; alpha4/beta4CHRNB4|CHRNA4unknown—
Neuronal acetylcholine receptor; alpha2/beta4CHRNB4|CHRNA2unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1984-04-30FDA—ORGANON USA INC

ATC classification

ATC codeTherapeutic hierarchy
M03AC03MUSCULO-SKELETAL SYSTEM › MUSCLE RELAXANTS › MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS › Other quaternary ammonium compounds

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Hyperthermia malignant256.2
Anaphylactic reaction251.9
Cardiac arrest221.3
Neuromuscular block prolonged183.3
Hypotension177.4
Bradycardia175.7
Delayed recovery from anaesthesia111.5
Anaphylactic shock104.5
Drug interaction101.6
Fear99.3
Post procedural complication99.3
Feeding intolerance93.2

Chemical structure

Molecular formulaC34H57N2O4
Molecular weight557.84 g/mol
CAS number50700-72-6
InChIKeyBGSZAXLLHYERSY-XQIGCQGXSA-N
PubChem CID39765
CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Vecuronium used for?

DrugCentral lists the following indications for Vecuronium: General anesthesia, Muscle relaxation, function and Skeletal Muscle Relaxation for Endotracheal Intubation.

How does Vecuronium work?

Its molecular targets in DrugCentral include CHRM1, CHRM4, CHRM5 and CHRM3.

When was Vecuronium first approved?

Vecuronium was first approved by the FDA in 1984.

What drug class does Vecuronium belong to?

Vecuronium is in the Nondepolarizing Neuromuscular Blocker class.

What is the chemical formula of Vecuronium?

Vecuronium has the molecular formula C34H57N2O4 and a molecular weight of 557.84 g/mol.

Browse: all drugs starting with V · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1984-04-30
AgencyFDA
Targets13
Indications3
FormulaC34H57N2O4
DrugCentral ID2811
Interactive profile